patents.google.com

ECSP993211A - PROTEASE INHIBITORS VI - Google Patents

  • ️Thu Jan 27 2000

ECSP993211A - PROTEASE INHIBITORS VI - Google Patents

PROTEASE INHIBITORS VI

Info

Publication number
ECSP993211A
ECSP993211A ECSP993211A ECSP993211A EC SP993211 A ECSP993211 A EC SP993211A EC SP993211 A ECSP993211 A EC SP993211A EC SP993211 A ECSP993211 A EC SP993211A Authority
EC
Ecuador
Prior art keywords
protease inhibitors
captesin
inhibition
diseases
graph
Prior art date
1999-11-09
Application number
Other languages
Spanish (es)
Inventor
Andrew D Gribble
Jason Witherington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1999-11-09
Filing date
1999-11-09
Publication date
2000-01-27
1999-11-09 Application filed filed Critical
1999-11-09 Priority to ECSP993211 priority Critical patent/ECSP993211A/en
2000-01-27 Publication of ECSP993211A publication Critical patent/ECSP993211A/en

Links

  • 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
  • 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
  • 206010065687 Bone loss Diseases 0.000 abstract 1
  • 230000008355 cartilage degradation Effects 0.000 abstract 1
  • 150000001875 compounds Chemical class 0.000 abstract 1
  • 239000002852 cysteine proteinase inhibitor Substances 0.000 abstract 1
  • 201000010099 disease Diseases 0.000 abstract 1
  • 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
  • 230000005764 inhibitory process Effects 0.000 abstract 1
  • 150000003839 salts Chemical class 0.000 abstract 1

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Este invento se refiere a compuestos de la fórmula I: (gráfico), en la que: n es 1 ó 2; o una de sus sales farmacéuticamente aceptables, que son inhibidores de cisteína-proteasas, particularmente captesina K, y son útiles en el tratamiento de enfermedades en las que la inhibición de la pérdida de huesos o de la degradación de cartílagos constituye un factor.This invention relates to compounds of formula I: (graph), wherein: n is 1 or 2; or one of its pharmaceutically acceptable salts, which are cysteine protease inhibitors, particularly captesin K, and are useful in the treatment of diseases in which inhibition of bone loss or cartilage degradation is a factor.

ECSP993211 1999-11-09 1999-11-09 PROTEASE INHIBITORS VI ECSP993211A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993211 ECSP993211A (en) 1999-11-09 1999-11-09 PROTEASE INHIBITORS VI

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993211 ECSP993211A (en) 1999-11-09 1999-11-09 PROTEASE INHIBITORS VI

Publications (1)

Publication Number Publication Date
ECSP993211A true ECSP993211A (en) 2000-01-27

Family

ID=42044199

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993211 ECSP993211A (en) 1999-11-09 1999-11-09 PROTEASE INHIBITORS VI

Country Status (1)

Country Link
EC (1) ECSP993211A (en)

Similar Documents

Publication Publication Date Title
CY1111130T1 (en) 2015-06-11 CATEGORY PROTECTION CATALOG Suspensions
ATE409482T1 (en) 2008-10-15 CATHEPSINCYSTEIN PROTEASE INHIBITORS
DE60329316D1 (en) 2009-10-29 PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER
ECSP044992A (en) 2004-04-28 INHIBITORS OF THE ALQUÍN-ARIL FOSFODIESTERASA-4
ATE354563T1 (en) 2007-03-15 SULFONE DERIVATIVES FOR INHIBITING GAMMA SECRETASE
DK1754475T3 (en) 2009-11-09 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice / ced-3 family of cysteine proteases
ECSP044998A (en) 2004-04-28 PIRROLO PIRIMIDINAS AS AGENTS FOR THE INHIBITION OF CYSTEINE PROTEASES
ATE416761T1 (en) 2008-12-15 PREVENTION AND TREATMENT OF INFLAMMATORY AND/OR IMMUNE-MEDIATED BONE LOSS
ECSP055696A (en) 2005-07-06 2-HYDROXI-1, 3-DIAMINOALCAN OIL
UY27774A1 (en) 2003-11-28 METALOPROTEIN INHIBITORS OF TRIARIL-OXI-ARIL-ESPIROPIRIMIDINA-2,4,6-TRIONA
SV2004001414A (en) 2004-05-07 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION WATERFALL. PC20535
ES2128283T1 (en) 1999-05-16 THROMBINE INHIBITOR PROPHARMACS.
DK1296671T3 (en) 2008-06-16 Gabapentin analogues for sleep disorders
UY27991A1 (en) 2004-03-31 POBROLIDONA DOMO INHIBITORS DERIVATIVES OF MAOB
MXPA03006224A (en) 2004-10-15 Inhibitors of cruzipain and other cysteine proteases.
AR013079A1 (en) 2000-12-13 SUBSTITUTED DERIVATIVES OF TETRAHIDROFURANO-3-ONAS, TETRAHIDROPIRANO-3- ONAS AND TETRAHIDROTIOFEN-3-ONAS, A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION OF A MEDICINAL PRODUCT USEFUL AS INTERMEDIATE PROTEIN INHIBITORS
ATE303384T1 (en) 2005-09-15 1-BIARYL-1,8-NAPHTHYRIDINE-4-ONE AS PHOSPHODIESETERASE INHIBITORS
AR021241A1 (en) 2002-07-03 PROTEASE INHIBITORS
ECSP034561A (en) 2003-06-25 PIPERAZINE BRIDGE DERIVATIVES
AR039664A1 (en) 2005-03-02 PHARMACEUTICAL COMPOSITION INCLUDED BY A LIPASE AND GLUCOMANAN INHIBITOR
NO20044549L (en) 2005-01-25 Bis-cyclic 6-alkalidene penes as beta-lactamase inhibitors
WO2001034565A3 (en) 2001-10-04 Protease inhibitors
AR039937A1 (en) 2005-03-09 DERIVATIVES OF AZETIDINE AS INHIBITORS OF TRIPSINE PROTEASES
ECSP993211A (en) 2000-01-27 PROTEASE INHIBITORS VI
SE0102921D0 (en) 2001-08-30 Pharmaceutically useful compounds